Find-Health-Articles.com - making medical research available to everyone
Research article summary (published 29 Sep 2002):
Free Full Text!
See links below

Mechanisms of action of midazolam on expression of contextual fear in rats.

Full Abstract

BACKGROUND: Midazolam may suppress conditioned fear after an aversive event by disrupting the memory trace formed during conditioning, by altering the emotional part of the aversive event, or by the combination of both effects. The purpose of the present study was to determine whether affective-related processes contribute to the amnesic-like effects of midazolam on aversive events. METHODS: The effects of acute administration of low doses of midazolam (0.37-3 mg kg(-1)) on fear conditioning (association between a neutral context and an aversive stimulus) and on innate anxiety in fearful surroundings were examined in rats. The effect of midazolam on the deleterious consequences of pre-exposure to the context (a non-aversive event) for subsequent fear conditioning was then compared with its effect on fear conditioning. The role of midazolam as an affective context was assessed by performing the testing phase under midazolam. Possible locomotor impairment or long-term effects of midazolam were controlled in additional experiments. RESULTS: Midazolam reduced both contextual fear conditioning and spontaneous fear. The deleterious effect of midazolam on pre-exposure to the context was of the same magnitude as its effect on the acquisition phase of fear conditioning. The effects of midazolam on both pre-exposure to the context and fear conditioning were unchanged when rats received a second injection of midazolam before the retention phase. CONCLUSIONS: Low doses of midazolam that do not impair locomotion suppress conditioned fear to the context by acting on memory processes rather than on affective or anxiolytic processes.

 

Author information

Author/s: Pain, L (L); Launoy, A (A); Fouquet, N (N); Oberling, P (P);

Affiliation: GRERCA, Hôpitaux Universitaires de Strasbourg and INSERM U405, Faculté de Médecine, Strasbourg, France.

Journal and publication information

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal: British journal of anaesthesia (Br J Anaesth), published in England. (Language: eng)

Reference: 2002-Oct; vol 89 (issue 4) : pp 614-21

Dates: Created 2002/10/23; Completed 2002/11/18; Revised 2006/11/15;

PMID: 12393364, status: MEDLINE (last retrieved date: 2/18/2009)

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MeSH Headings (categories) shown below.

Note: Bold headings indicate primary MeSH headings or qualifiers.

Associated Chemicals: Anti-Anxiety Agents (0) ; Midazolam (59467-70-8)

Related articles

These are the most related articles currently in our database:

See 100+ related articles.

Related Article Map

8/30/1997
7/14/2008
Higher Relevance Score (15)
Lower Relevance Score (13)

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a larger map of 100+ related articles.

© Advanogy LLC 2003-2010 - All rights reserved. Terms of Use | Contact Us | Index